Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Fritsche

Showing results (41-50 of 214) with videos related to

Pageof 22
Sort By:
The Journal of Pediatrics|December 12, 2018
Beta-Hemolytic Nongroup A Streptococcal Pharyngitis in ChildrenHolly M Frost, Thomas R Fritsche, Matthew C Hall
WMJ : Official Publication of the State Medical Society of Wisconsin|August 15, 2014
A clinical, diagnostic, and ecologic perspective on human anaplasmosis in the Upper MidwestAnna M Schotthoefer, Jennifer K Meece, Thomas R Fritsche
Journal of Chemotherapy (Florence, Italy)|May 10, 2008
Update of the activity of cefditoren and comparator oral beta-lactam agents tested against community-acquired Streptococcus pneumoniae isolates (USA, 2004-2006)T R Fritsche, D J Biedenbach, R N Jones
Journal of Clinical Microbiology|March 7, 2006
Accuracy of three automated systems (MicroScan WalkAway, VITEK, and VITEK 2) for susceptibility testing of Pseudomonas aeruginosa against five broad-spectrum beta-lactam agentsHelio S Sader, Thomas R Fritsche, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|December 11, 2007
Tigecycline activity tested against 11808 bacterial pathogens recently collected from US medical centersAna C Gales, Helio S Sader, Thomas R Fritsche
Cornea|May 1, 1993
Stability and activity of vancomycin in corneal storage mediaT D Lindquist, B P Roth, T R Fritsche
Diagnostic Microbiology and Infectious Disease|January 29, 2008
In vitro potency evaluations of various piperacillin/tazobactam generic products compared with the contemporary branded (Zosyn, Wyeth) formulationRonald N Jones, Thomas R Fritsche, Gary J Moet
Diagnostic Microbiology and Infectious Disease|August 1, 2006
Influence of patient age on the frequency of occurrence and antimicrobial resistance patterns of isolates from hematology/oncology patients: report from the Chemotherapy Alliance for Neutropenics and the Control of Emerging Resistance Program (North America)Jeffrey T Kirby, Thomas R Fritsche, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|February 13, 2007
Review of the spectrum and potency of orally administered cephalosporins and amoxicillin/clavulanateHelio S Sader, Michael R Jacobs, Thomas R Fritsche
Diagnostic Microbiology and Infectious Disease|March 27, 2007
In vitro activity of garenoxacin tested against a worldwide collection of ciprofloxacin-susceptible and ciprofloxacin-resistant Enterobacteriaceae strains (1999-2004)Helio S Sader, Thomas R Fritsche, Ronald N Jones
Pageof 22

Showing results (41-50 of 214) with videos related to

Sort By:
Pageof 22
The Journal of Pediatrics|December 12, 2018
Beta-Hemolytic Nongroup A Streptococcal Pharyngitis in ChildrenHolly M Frost, Thomas R Fritsche, Matthew C Hall
WMJ : Official Publication of the State Medical Society of Wisconsin|August 15, 2014
A clinical, diagnostic, and ecologic perspective on human anaplasmosis in the Upper MidwestAnna M Schotthoefer, Jennifer K Meece, Thomas R Fritsche
Journal of Chemotherapy (Florence, Italy)|May 10, 2008
Update of the activity of cefditoren and comparator oral beta-lactam agents tested against community-acquired Streptococcus pneumoniae isolates (USA, 2004-2006)T R Fritsche, D J Biedenbach, R N Jones
Journal of Clinical Microbiology|March 7, 2006
Accuracy of three automated systems (MicroScan WalkAway, VITEK, and VITEK 2) for susceptibility testing of Pseudomonas aeruginosa against five broad-spectrum beta-lactam agentsHelio S Sader, Thomas R Fritsche, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|December 11, 2007
Tigecycline activity tested against 11808 bacterial pathogens recently collected from US medical centersAna C Gales, Helio S Sader, Thomas R Fritsche
Cornea|May 1, 1993
Stability and activity of vancomycin in corneal storage mediaT D Lindquist, B P Roth, T R Fritsche
Diagnostic Microbiology and Infectious Disease|January 29, 2008
In vitro potency evaluations of various piperacillin/tazobactam generic products compared with the contemporary branded (Zosyn, Wyeth) formulationRonald N Jones, Thomas R Fritsche, Gary J Moet
Diagnostic Microbiology and Infectious Disease|August 1, 2006
Influence of patient age on the frequency of occurrence and antimicrobial resistance patterns of isolates from hematology/oncology patients: report from the Chemotherapy Alliance for Neutropenics and the Control of Emerging Resistance Program (North America)Jeffrey T Kirby, Thomas R Fritsche, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|February 13, 2007
Review of the spectrum and potency of orally administered cephalosporins and amoxicillin/clavulanateHelio S Sader, Michael R Jacobs, Thomas R Fritsche
Diagnostic Microbiology and Infectious Disease|March 27, 2007
In vitro activity of garenoxacin tested against a worldwide collection of ciprofloxacin-susceptible and ciprofloxacin-resistant Enterobacteriaceae strains (1999-2004)Helio S Sader, Thomas R Fritsche, Ronald N Jones
Pageof 22